Background: Therapeutic suits or clothing whether associated with intensive protocols or not, became popular in the rehabilitation of children with cerebral palsy. Studies have reported positive effects of these suits on children's posture, balance, motor function and gait. A summary of current literature may help guide therapeutic actions. Objective: To evaluate the available evidence on the effects of interventions based on the use of therapeutic suits in the treatment of impairments and functional limitations of children with cerebral palsy. Method: Three independent reviewers searched for experimental studies on MEDLINE, SciELO, BIREME, LILACS, PEDro and CENTRAL databases, between October and December 2015 and updated in May 2016. The reviewers evaluated the methodological quality of selected studies using the Checklist for Measuring Quality. the Full Body Suit and TheraSuit showed very low quality evidence while the evidence for TheraSuit/AdeliSuit protocols were of low quality. Conclusion: Enthusiasm with new therapeutic approaches that argue modifications in the neuromusculoskeletal impairments and functional limitations of children with cerebral palsy need to be guided by scientific evaluation. The low quality of evidence suggests caution in recommending the use of these therapeutic suits. New studies could change the findings of this review.
Introduction
Rehabilitation of children with cerebral palsy (CP) has focused on minimizing impairments and disabilities, promoting functioning in patients' body structures and functions, activity and participation, 1 in addition to improving their quality of life. 2 New technologies have been used to support and/or enhance the engagement of these children in activities and tasks in different environments. 2 One example is the use of rigid and dynamic orthoses. These devices are intended to improve posture and movement, prevent deformities and facilitate functional performance. 3 Since the 1990s, different types of therapeutic suits have been used for children with CP. 4---6 These suits are dynamic orthoses available in various models. Body suit type orthoses are custom manufactured, made of Lycra, fit tight to the body and may cover the trunk and limbs, exerting a compressive force on the body. 4, 7 TheraTogs are elastic straps attached by Velcro onto a vest, onto shorts and onto anchors on the legs and feet. These technologies are intended to improve postural alignment, joint stability and movement efficiency. 8 TheraSuit, AdeliSuit and PediaSuit were created from a prototype developed for Russian astronauts so they could perform counter-resistance exercises in zero gravity situations. 5, 9, 10 These models have hooks that anchor a system of individually fixed elastic tubes that exert traction between the trunk and pelvis and between the pelvis and lower limbs. 9 They have become popular in many countries and are often associated with specific treatment protocols. The TheraSuit Method (TSM) and AdeliSuit Therapy (AST) protocols 9, 11, 12 consist of intensive treatments, including vigorous strengthening and stretching exercises and training of specific motor activities, during which the child wears the suits. 9, 13 Therapeutic suits have gained popularity in pediatric rehabilitation and are widely commercialized. Families of children with CP have made efforts to acquire these suits and submit their children to these very expensive supplementary treatments. 12---16 There are clinical claims that the use of these dynamic orthoses can modify joint alignment and contribute to the strengthening and/or stretching of certain muscle groups, thereby affecting posture, balance, coordination, gross motor function, hand function and gait of children with CP and other health conditions. 4---11 The mechanisms of action proposed to explain such functional changes are the compression and/or continuous tension exerted by the suits' elastic elements on the child's musculoskeletal system. These elastic elements are systematically adjusted based on individual needs and limitations. 5, 8 In addition to the clinical claims and families' positive expectations, studies have provided scientific evidence on the effects of these suits regarding posture and movement of children with CP. 13, 16 A recent systematic review with meta-analysis showed that the effect of TSM and AST protocols on the functioning of children with CP was of small magnitude. 13 As this review focused on specific intensive training protocols, which involved elements other than suit wearing, no conclusions regarding the effects of alternative types of therapeutic suits (e.g., TheraTogs) worn by children with CP irrespectively of intensive training can be drawn. Moreover, given that the commercially available interventions include therapeutic suits associated or not with intensive protocols, it is necessary to evaluate the isolated and combined effects of these two elements (i.e., intensive training and suit wearing). It is possible that positive evidence of one element does not reflect the effect of the other, nor the combination of both. Therefore, the objective of this systematic review was to evaluate the available evidence regarding the effects of interventions based on the use of therapeutic suits (combined or not with intensive protocols) on the treatment of functional limitations and disabilities in children with CP. The summary and critical analysis of this literature may guide clinical decision making regarding these resources and provide scientific evidence to enable rehabilitation services to make judicious choices about the provision of these types of treatment.
Methods
Three independent examiners performed literature searches on MEDLINE, SciELO, BIREME, LILACS, PEDro and Cochrane Central Register of Controlled Trials databases. The searches were conducted between October and December 2015 and updated in May 2016. These searchers were standardized and involved no restrictions of year of publication. The search strategy, along with the inclusion and exclusion criteria, is shown in Table 1 . As the use of therapeutic suits in child rehabilitation is a relatively new modality of treatment, studies with different experimental designs were included.
After reading the titles and abstracts, duplicate studies or studies that did not meet the inclusion criteria were excluded. The remainder were selected for full reading. An Studies included in this review (n=13) Figure 1 Flowchart illustrating the article selection process, according to the PRISMA 17 structure for a systematic review on the effects of interventions with therapeutic suits on impairments and functional limitations of children with cerebral palsy. active manual search on the articles' reference lists was performed to identify potentially relevant studies. Fig. 1 illustrates the selection process. 17 The following data was extracted from the selected articles: author and year of publication; study design; sample size and characteristics; details of the intervention: frequency, duration, suit type and settings, activities performed and control intervention; outcomes analyzed using inferential statistics and the instrumentation used; and the results obtained. Due to heterogeneity regarding the therapeutic suits types, intervention protocols and samples' characteristics across the studies, it was not possible to conduct a meta-analysis.
Each study's methodological quality was evaluated independently by three examiners using the Checklist for Measuring Study Quality, 18 which is a valid and reliable instrument recommended to be used in systematic reviews that include studies with different experimental designs. 18, 19 The checklist evaluates the methodological quality of articles according to the following aspects: reporting (10 items); external validity (3 items); internal validity ---bias (13 items); and statistical power (one item). 18, 19 Twenty-five items are given a score of zero (0) if the study does not meet the requirements or a score of one (1) if the study meets the item requirements. Item 27 on statistical power is scored between zero (0) and five (5), with higher scores for studies with larger samples. Item five, related to principal confounders, is scored between zero (0) and two (2) . The maximum possible score is 32. 18 Interrater reliability for the use of the checklist has been verified using the Intraclass Correlation Coefficient (ICC) type 2.1, a coefficient that measures absolute agreement with twoway random analysis. 20 Consensus regarding disagreements between examiners in the checklist application was reached after a discussion mediated by the first author.
The Grading of Recommendations Assessment, Development and Evaluation (GRADE) 21, 22 summarized evidence regarding the therapeutic suits effects on each functioning component 1 and classified the strength of the recommendation for this therapeutic resource. In GRADE, evidence is initially categorized into four levels (i.e., high, moderate, low, and very low) depending on the study design. Afterwards, several methodological attributes from the studies are taken into account and may cause the level of quality of the evidence available for each outcome to be increased (i.e., large effect size, dose-response gradient, and residual confounding factors that increase the confidence in the estimate) or decreased (i.e., methodological limitations, risk of bias, inconsistency, inaccuracy, indirect evidence and publication bias). 21, 22 The strength of the recommendation is classified as strong or weak and expresses an indication that a treatment should be adopted in clinical practice or not by considering potential advantages and disadvantages. 21, 22 The GRADE recommendations were performed by the first author.
Results
From an initial total of 273 articles, 13 met the criteria and were included in this review (Fig. 1) . The studies were published between 2000 and 2015. Two studies investigated the effects of the Full Body Suit (FBS), two investigated the Dynamic Elastomeric Fabric Orthose (DEFO), three investigated TheraTogs, and six investigated the TSM or AST protocols. A total of 285 children with different clinical types of CP, aged between three and 17 years, with Gross Motor Function Classification System (GMFCS) 23 levels between I and IV, made up the sample. In terms of the designs, six studies were Randomized Controlled Trials (RCTs), five were quasi-experimental designs (QED), and two were single-subject experimental designs (SSED). Interventions with the suits ranged from three to 18 weeks, with usage times ranging between 30 min and 12 h/day. Different standardized instruments evaluated outcomes focusing on (1) body structures and functions and (2) activity.
1 A summary of the studies is presented in Table 2 .
Dynamic Elastomeric Fabric Orthose
Two studies tested the effects of DEFO (neoprene pants that exert pressure on the pelvis and promote hip external rotation and abduction and knee extension) 24 ,25 on children with diplegic CP presenting with a crouch gait. In both studies, subjects wore the suit from four to eight hours a day for six weeks. Matthews et al. 24 showed that five of the eight subjects significantly increased walking speed after intervention compared to baseline. The fact that only some of the participants showed improvements might be attributed to (1) the lack of control of the activities performed by each participant during the intervention period and (2) the lack of standardization regarding suit usage time among children. 24 Bahramizadeh et al. 25 showed improvement in knee alignment in the standing position, in the DEFO wearing assessment condition, after the intervention period. Wearing this suit did not lead to significant difference in postural control between CP and normally developing children.
25

The Full Body Suit
Two studies, conducted by the same group of researchers, investigated the effects of the FBS. 26, 27 In these studies, children wore the suit for up to six hours/day for six weeks while maintaining their usual treatments and orthoses. 26, 27 Nicholson et al. 27 revealed significant differences in self-care and mobility skills and in mobility independence, whereas Rennie et al. 26 found no effect on any Pediatric Evaluation of Disability Inventory (PEDI) scales nor on proximal and distal stability during walking. It is possible that the discrepancy in their results might be attributed to type II error, wherein one study's small sample size 26 precluded demonstration of the effects that were shown in the other study.
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TheraTogs
Three studies tested the effects of TheraTogs in children with diplegic CP wearing the suits for 12 h/day for 12 weeks. 28---30 El-Kafy and El-Shemy 28 compared a control group (CG) submitted to an exercise program, with an experimental group (EG) who undertook the same program in addition to wearing TheraTogs. Their results showed a significant difference between groups for postural alignment and gait kinematics, favoring the EG. Within-groups comparison revealed that CG did not improve after treatment. In addition, after the intervention, evaluation of the EG wearing the suit revealed significant improvements in all parameters compared to the conditions without the suit evaluated Rotational angles of the hip and knee in the standing position, Foot progression angle during the gait cycle and gait speed (3D-MAS).
Between groups: statistically significant differences for all the kinematic parameters, favoring the EG (p < 0.01), with large effect (1.0 < d < 1.91). Within-groups: CG: no significant differences post-treatment (p > 0.05); EG: significant differences between the three assessments for all the kinematic parameters; the ''wearing suit'' condition was the one in which participants showed the best results (p < 0.01), with large effect CG vs EG ''wearing suit'' (2.79 < d < 3.98). 
Gross motor function (GMFM-88).
Between groups: significant differences in GMFM-88 scores between groups, favoring the EG (p = 0.03) with large effect (d = 0.83). Within-groups: both groups showed significant improvement in GMFM-88 scores after intervention (p < 0.001), with small effect to CG (d = 0.11) and small effect to EG (d = 0.4) Gross motor function (GMFM-66). FS and CA (PEDI).
Between groups: no significant differences between groups neither in GMFM-66 scores (p = 0.48), nor in PEDI subscales scores 
Gross motor function (GMFM-66). Energy cost during stair-climbing (MEI).
Between groups: no significant differences between groups. Within-groups: EG ---significant improvement in GMFM-66 scores (p < 0. Subjects were randomized in 3 groups: CG (n = 12), EG-AST (n = 12) and EG-MAST (n = 12).
CG: NDT (passive exercises in the first hour and active exercises in the second hour). EG-AST: AdeliSuit Therapy. EG-MAST: Modified AdeliSuit Therapy (NDT in the first hour and AdeliSuit in the second hour). Subjects in all 3 groups were treated for 4 weeks (2 h/daily, 5 days/week).
Gross motor function (GMFM-66).
Between groups: significant differences (p = 0.000); the differences were between EG-MAST and EG-AST favoring the EG-MAST (p = 0.000) small effect (d = 0.41); and between EG-MAST and CG favoring the EG-MAST (p = 0.000) moderate effect (d = 0.56); no significant differences between EG-AST and CG (p = 0.272). Within-groups: the 3 groups improved in GMFM-66 scores post-treatment vs baseline (p < 0.001) with small to large effect (0.29 < d < 0.88); no significant differences within-groups were identified in the follow-up (p = 0.637). before and after intervention. 28 El-Kafy 29 compared the following three groups: CG ---neurodevelopmental treatment (NDT); EG1 ---NDT plus TheraTogs; and EG2 ---NDT plus TheraTogs and ground reaction orthosis. After the interventions, although the three groups showed improvements in all gait kinematic parameters, EG2 showed better results than CG and EG1, demonstrating that combining rigid and dynamic orthoses might potentiate gait performance in diplegic children with a crouch gait. 29 Flanagan et al. 30 demonstrated a positive effect of TheraTogs on gross motor skills and balance after intervention and at follow-up. Changes in gait kinematics were found with the suit on (i.e., increase in peak hip extension and pelvic alignment). Even after prolonged use, the effects of TheraTogs were demonstrated only when children were wearing the suit. 30 
TheraSuit Method and AdeliSuit Therapy Protocols
Two studies 31, 32 investigated the effects of the TheraSuit associated with intensive protocols on activity outcomes 1 of children with CP. In both studies, participants were submitted to exercise programs, with one group (EG) wearing the suit and the other group (CG) not wearing it. Alagesan and Shetty 31 found a significant improvement in gross motor function in the EG compared to the CG. Bailes et al. 32 found improvements in gross motor function, functional abilities and caregiver assistance in both groups but found no difference between CG and EG post-treatment. 32 Although both studies showed significant effects following the use of this suit, there were inconsistencies in groups' comparisons due to differences in the treatment characteristics. For example, in the study conducted by Alagesan and Shetty 31 the exercise program was based on conventional therapy, whereas Bailes et al. 32 used the original TSM protocol. Two studies 33, 34 compared AST to NDT and found no difference in gross motor function in groups of children with different CP types. Mahani et al. 34 also compared NDT and AST to the modified AST (MAST) protocol, which associates NDT and AST techniques. The group submitted to MAST showed better results in gross motor function, revealing the positive effects of combining a traditional technique with the use of this therapeutic suit. 34 Christy et al. 35 investigated the effects of TSM on 17 children with CP and found a significant improvement in gross motor function, overall functioning, performance and satisfaction perceived by caregivers regarding children's performance of functional tasks. 35 Ko et al. 36 evaluated the effects of AST in a child with diplegic CP undergoing weekly sessions for 18 weeks. Improvements in gross motor function, gait speed and balance were observed.
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Evaluation of the methodological quality of the studies
The consistency between the three researchers regarding the use of the Checklist for Measuring Quality for measuring study quality 18 was very good 20 (ICC 2.1 = 0.89 ± 0.09). Table 3 shows the scoring for each study for each item. Scores varied according to the design, with higher values obtained by RCTs, 29---34 followed by QEDs 25---28, 35 and SSEDs. 24, 36 Studies analyzing the effects of FBS obtained scores of 37% 26 and 40%, 27 studies of DEFO obtained 43% 24 and 53%, 25 TheraTogs studies obtained 37%, 28 59% 29 and 68%, 30 TSM and AST studies 31---36 scored between 34% and 90% of the total checklist value. Overall, the studies obtained good scores in the description of objectives, methods and results. Low scores were related to external validity items and the blinding of subjects, therapists and examiners. The item regarding consistency in the intervention was scored only by studies that verified the effects of TSM and AST; studies evaluating the effects of FBS, DEFO and TheraTogs received a zero score in this item because they did not provide information about the control of suit usage time. Most studies obtained a maximum score on the item related to statistical power (score 5), because study groups had eight or more subjects, leading to the checklist' criteria for maximum scoring on that item. 18 The summarized evaluation by GRADE suggests that the quality of evidence on the use of the suits was low to very low for body structure and function and activity 1 outcomes. Such classification was primarily due to the small number of RCTs and to certain methodological limitations in the studies, resulting in weak recommendations for the use of therapeutic suits. Table 4 shows the application of GRADE with respect to the body of evidence available for the outcomes investigated for each suit.
Discussion
This systematic review examined the available evidence on the effects of therapeutic suits associated or not with intensive protocols on the functioning of children with CP. Four main suit models were found in the 13 selected studies. Generally, the postural alignment and gait kinematic improved in children with CP who wore the suits, especially when they were wearing them. However, the quality of evidence is low and the recommendation for therapeutic suits in the treatment of impairments and limitations of children with CP is weak due to uncertainty regarding the advantages and disadvantages of wearing the investigated suits.
The review did not find any effect arising from the isolated use of TheraSuit and AdeliSuit without an associated intensive treatment protocol in the functioning of children with CP. The association of the suits with intensive protocols (e.g., TSM/AST) has increased expectations of good results in the rehabilitation of children and youth with CP. 2, 12, 14, 15 Among the selected studies, Bailes et al., 32 with better methodological quality, showed that there was no difference in the gross motor function and functional skills of children with CP when submitted to the TSM with or without the suit. The effects found might be due to the intensity of treatment and cannot be attributed to the isolated use of TheraSuit. 32 In addition, Bar-Haim et al. 33 and Mahani et al. 34 revealed no difference between those interventions and other therapies when performed with the same intensity and duration. It is possible that the high intensity of training, instead of the specificity of the TSM and AST protocols, may be responsible for the improvements presented by the children submitted such interventions. This review corroborates a recent systematic review and meta-analysis 13 that examined the effects of these therapies on the functioning of children with CP. The authors concluded that the available evidence Bar-Haim et al. 33 Mahani et al. 34 Christy et al. 35 Ko et al. Bar-Haim et al. 33 Mahani et al. 34 Christy et al. 35 Ko et al. 36 18. Appropriate statistical tests was not sufficient to draw conclusions about the advantages and disadvantages of the TSM and AST in the treatment of gross motor function of children with CP. 13 The DEFO and TheraTogs demonstrated positive effects 24,25,28---30 on postural alignment and gait kinematics of children with diplegic CP. These individuals often present hip internal rotation and flexion, knee flexion, and tibia internal rotation, resulting in a gait pattern named ''crouch gait''. 37 Positive effects on the posture and gait of these children were previously documented with subjects wearing rigid orthoses. 3, 38 Hence, the association of rigid orthoses with a therapeutic suit (i.e., a dynamic orthoses) seems to potentiate the individual effects of each of these interventions in the diplegic children's gait kinematics. 30 While rigid orthoses provide greater joint stability, dynamic orthoses have the potential to facilitate the execution of movements and their combination may perpetuate long-term positive changes in the musculoskeletal system of diplegic children. 39, 40 FBS, whose compressive characteristic aims to promote stability, did not demonstrate any improvements in gait stability when used in children with different CP types, even when the child was wearing the suit during the assessments. 26, 27 Additionally, Rennie et al. 26 and Nicholson et al. 27 have reported parents' complaints concerning the discomfort associated with FBS, including changes in the urinary system and constipation, movement restrictions, warmth and eczema. These discomforts contributed to most children not enjoying the use of the suit and reporting they would not consider wearing it again.
26,27 Knox 41 followed a series of eight cases of children with CP who wore a suit with the same compressive characteristics for four weeks. Three children withdrew from participating in the study because they could not adapt to the suit. Those who completed the intervention stated that the suit was tight, hot, and difficult to put on and take off, with difficulties in using the toilet. 41 The very low evidence of FBS's efficacy, in association with its adverse effects, result in a strong recommendation that it should not be used in the rehabilitation of children with CP.
The intensity and duration of therapeutic suit treatment varied greatly among the studies. Positive effects on body structure and function outcomes were found in situations of reduced intensity and duration 25 (i.e., wearing DEFO for four to six hours/day for six weeks) as well as in situations of higher intensity 28---30 and duration (i.e., wearing TheraTogs for 12 h/day for 12 weeks). However, long-term effects were not systematically investigated. Only Flanagan et al., 30 investigated the isolated effects of TheraTogs, and found stable gains in gross motor skills in the follow-up period. 30 Due to the differences among therapeutic suits and the time regimens in which they were implemented, the available evidence is not conclusive regarding the optimal intensity of suit wearing to guarantee their efficacy.
This systematic review has limitations that need to be considered. The criteria for selecting studies was met with a language restriction (only studies written in English, Portuguese or Spanish were included), resulting in the exclusion of seven potentially relevant studies published in Russian. Besides that, no literature searches were conducted in databases with no free access (e.g., EMBASE), which may have hindered the identification of potentially relevant studies. The Checklist for Measuring Study Quality presented difficulties regarding the interpretation and application of some items, especially those concerning external validity, which caused disagreements between the evaluators. These disagreements were minimized by discussion to reach a consensus. Finally, it was not possible to add a meta-analysis to this systematic review because the studies tested various therapeutic suit models in samples with different characteristics and compared different protocols.
Recommendations for future studies
The selected studies did not have sufficient information about (1) the direction and level of tension applied to the elastic elements in order to adjust the suits and (2) the exercises and activities conducted during the therapy sessions. Detailing the procedures is important since these elements constitute the mechanisms underlying therapeutic changes. Additionally, there is a lack of studies with a high level of evidence that identified the dose-response of this therapeutic resource (i.e., the sufficient and appropriate intensity and duration of suit wearing for the effects on different functional components). Finally, the studies lacked information about which children with CP (i.e., descriptive characteristics including age, topographic and severity) might be better candidates for obtaining the effects of different therapeutic suit models. Most studies that were part of this review included only children with mild to moderate severity of CP (GMFCS I---III) and with diplegic CP type, limiting the results for these subgroups.
Conclusion
The suits DEFO and TheraTogs seem to improve the postural alignment and gait performance in children with diplegic CP. However, the quality of current available evidence ranges from low to very low for the different suit models tested. The recommendation to use these suits in the treatment of children with CP is weak. Future studies that address the inconclusive elements indicated in this review may help to endorse or refute the effects of these dynamic orthoses and will most certainly affect the strength with which they can be recommended.
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